首页> 外文期刊>魚病研究 >Therapeutic Efficacy of Oral Administration of Fosfomycin on Experimentally Induced Edwardsiellosis in Japanese Flounder
【24h】

Therapeutic Efficacy of Oral Administration of Fosfomycin on Experimentally Induced Edwardsiellosis in Japanese Flounder

机译:口服磷霉素对实验性比目鱼爱德华氏病的治疗效果

获取原文
获取原文并翻译 | 示例
       

摘要

Juvenile Japanese flounder Paralichthys olivaceus were immersion-challenged (2.0 x 10(6) CFU/mL, 60 min) with Edwardsiella tarda NUF806 strain. From the following day, diets containing fosfomycin (FOM) calcium were administrated orally at concentrations of 20, 40 or 80 mg potency/kg body weight/day for 6 consecutive days. Cumulative mortality of fish during the observation period of 21 days after the drug administration was significantly lower in all groups of FOM-treated fish than that in the control group. In addition, NUF806 strain and recent clinical isolates (n = 30) of E. tarda examined were all susceptible to FOM, with MIC of 2-4 mu g/mL when estimated using the glucose-6-phosphate-containing Mueller-Hinton broth. The results suggest that FOM is a promising candidate for the treatment of edwardsiellosis in cultured Japanese flounder.
机译:将日本小比目鱼Paralichthys olivaceus用爱德华氏菌tarda NUF806菌株浸没挑战(2.0 x 10(6)CFU / mL,60分钟)。从第二天开始,连续6天以20、40或80 mg效力/ kg体重/天的浓度口服含磷霉素(FOM)钙的饮食。在用FOM治疗的所有组中,给药后21天的观察期内鱼的累积死亡率显着低于对照组。此外,所检查的大肠杆菌的NUF806菌株和近期临床分离株(n = 30)均易受FOM感染,使用含6-磷酸葡萄糖的Mueller-Hinton肉汤估计其MIC为2-4μg / mL。 。结果表明,FOM是一种有前途的候选物,可用于治疗养殖的日本比目鱼中的埃德氏病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号